The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy
C. Strange (Charleston, United States of America), N. Mcelvaney (Dublin, Ireland), C. Vogelmeier (Marburg, Germany), M. Marin-Galiano (Düsseldorf, Germany), M. Haensel (Marburg, Germany), X. Zhang (King of Prussia, United States of America), Y. Chen (King of Prussia, United States of America), O. Vit (Bern, Switzerland), M. Wencker (Loerzweiler, Germany), K. Chapman (Toronto, Canada)
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Strange (Charleston, United States of America), N. Mcelvaney (Dublin, Ireland), C. Vogelmeier (Marburg, Germany), M. Marin-Galiano (Düsseldorf, Germany), M. Haensel (Marburg, Germany), X. Zhang (King of Prussia, United States of America), Y. Chen (King of Prussia, United States of America), O. Vit (Bern, Switzerland), M. Wencker (Loerzweiler, Germany), K. Chapman (Toronto, Canada). The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy. 349
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: